Single Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia
Clinical trial NCT04176991 · COMPLETED
Trial details
- NCT number
- NCT04176991
- Sponsor
- Larimar Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-11
- Primary completion
- 2020-10-31
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.